retatrutide clinical trial A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Retatrutide Meets Phase 3 Weight-Loss

This strongly suggests that the Biden team was not up to speed on GLP-1s in the first place, and was instead myopically focused on all things Ozempic (the name frequently used in the media when referring to semaglutide for weight loss, though this is actually the drugs brand name for its type 2 diabetes indication)

Limitations While participants were matched between the GLP-1RA and control groups, our sample size was small

Use of Glucagon-Like Peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: A review

Both are manufactured by Eli Lilly with rigorous quality controls, standardized dosing pens, and comprehensive prescribing information

But recently, people in the sober and sober-curious community have been asking: Can GLP-1s help with alcohol cravings, too

Small studies have suggested a parallel reduction in intrapancreatic fat content following initiation of GLP-1RA 52